Search for: "Pfizer Inc." Results 281 - 300 of 1,515
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2016, 5:19 am
Pfizer, Inc., 153 S.W.3d 758, 766 (Ky. 2004) (DTC exception “recognized only by New Jersey”); Mendez Montes De Oca v. [read post]
19 Feb 2016, 1:30 pm by Tom Lamb
As for what little has happened since then concerning this proposed Viagra MDL case, we turn to this January 4, 2016 news report, "JPMDL Won’t Expedite Hearing On Viagra Skin Cancer MDL Motion": The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 29 denied a joint request by Pfizer Inc. and Viagra plaintiffs to place a motion for a skin cancer multidistrict litigation on the panel’s Jan. 28 agenda (In Re: Viagra Products Liability Litigation, MDL… [read post]
17 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
15 Feb 2016, 9:59 pm by Patent Docs
By Donald Zuhn -- Last month, in Pfizer, Inc. v. [read post]
14 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
14 Feb 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law Two whistleblowers brought suit against Pfizer’s Wyeth Pharmaceutical Inc. [read post]
3 Feb 2016, 4:00 am by Alan Macek
Wyeth and Pfizer Canada Inc., 2011 FC 1169 at 34 reversed on other grounds 2012 FCA 141, Louis Vuitton Malletier S.A. v. [read post]
28 Jan 2016, 9:02 am by Gene Pierson
Patent Term Adjustment (PTA) is utilized by the Patent Office so that an inventor’s patent protection is not limited by delays caused by the Patent Office. [read post]
28 Jan 2016, 6:03 am
In October 2015, press reports began appearing suggesting that Pfizer Inc., one of the world’s largest pharmaceutical companies, and Allergan, an Irish publicly traded pharmaceutical company, were considering entering into the largest inversion in history. [read post]
21 Dec 2015, 3:00 am by Paul Caron
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]